Flindr Therapeutics
Signal active
Organization
Contact Information
Overview
Flindr Therapeutics, a private biotech company develops next-generation precision oncology treatments.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2020
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Flindr Therapeutics headquartered in Europe, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $513.6M in funding across 24 round(s). With a team of 1-10 employees, Flindr Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Flindr Therapeutics, raised $21.4M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
2
Investors
8
Lead Investors
0
Total Funding Amount
$21.4M
Details
1
Flindr Therapeutics has raised a total of $21.4M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Early Stage Venture | 21.4M |
Investors
Flindr Therapeutics is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Swanbridge Capital | - | FUNDING ROUND - Swanbridge Capital | 21.4M |
| Tine Bekaert | - | FUNDING ROUND - Tine Bekaert | 21.4M |
| Flindr Therapeutics | - | FUNDING ROUND - Flindr Therapeutics | 21.4M |
| Flanders Future Techfund | - | FUNDING ROUND - Flanders Future Techfund | 21.4M |
Recent Activity
There is no recent news or activity for this profile.